A split-mouth, randomized, triple-blind, placebo-controlled study to analyze the pre-emptive effect of etoricoxib 120 mg on inflammatory events following removal of unerupted mandibular third molars.

Abstract

Pain after third molar extraction has been considered the most suitable pharmaceutical model to evaluate acute pain. This study aimed to evaluate the pre-emptive analgesic/anti-inflammatory efficacy of etoricoxib 120 mg following mandibular third molar surgery. A split-mouth, randomized, triple-blind, placebo-controlled study was conducted with patients… (More)
DOI: 10.1016/j.ijom.2015.06.012

Topics

Cite this paper

@article{Costa2015ASR, title={A split-mouth, randomized, triple-blind, placebo-controlled study to analyze the pre-emptive effect of etoricoxib 120 mg on inflammatory events following removal of unerupted mandibular third molars.}, author={F W G Costa and E C S Soares and D F S Esses and P G deB Silva and Tmm Bezerra and Henrique Clasen Scarparo and Thyciana Rodrigues Ribeiro and C S R Fonteles}, journal={International journal of oral and maxillofacial surgery}, year={2015}, volume={44 9}, pages={1166-74} }